NEW YORK (Reuters Health) Feb 25 – Many hospitalized patients receive metformin therapy despite having contraindications that increase their risk of lactic acidosis, according to a report published in the February 25th issue of the Archives of Internal Medicine.
The product labeling for metformin identifies several clinical factors or patient characteristics that increase the lactic acidosis risk. However, the current findings suggest that many prescribers are unaware of these prescribing guidelines.
מקור:
In more than one-quarter of hospital admissions Arch Intern Med 2002;162:434-437.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!